Eplerenone for chronic central serous chorioretinopathy
Riccardo Sacconi +2 more
openalex +2 more sources
Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024. [PDF]
Ji K +8 more
europepmc +1 more source
Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease [PDF]
Matthieu Soulié +8 more
openalex +1 more source
Selective and nonselective mineralocorticoid receptor antagonists in central serous chorioretinopathy: systematic review and meta-analysis. [PDF]
Park JY, Jang Y, Hahn S.
europepmc +1 more source
Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Estimation of Dapagliflozin and Eplerenone in Bulk and Synthetic Mixture [PDF]
Prexa Manojbhai Tandel, H. B. Mehta
openalex +1 more source
Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome
Tsuyoshi Homma +5 more
openalex +2 more sources
The Role of Aldosterone in Vascular Permeability in Diabetes. [PDF]
Aleksiejczuk M +9 more
europepmc +1 more source

